Neuromodulation News and Research

RSS

Brain scans reveal lower serotonin transporters in people with mild cognitive impairment

In a study looking at brain scans of people with mild loss of thought and memory ability, Johns Hopkins researchers report evidence of lower levels of the serotonin transporter -- a natural brain chemical that regulates mood, sleep and appetite.

14 Aug 2017

Xavant Technology's neuromodulation device receives FDA clearance for treatment of chronic intractable pain

Xavant Technology (Pty) Ltd today announced that the U.S. Food and Drug Administration cleared their Stimpod NMS460. With the U.S. patent awarded on proprietary hybrid pulsed radio frequency (PRF) waveform, this non-invasive neuromodulation device is focused on the symptomatic relief and management of chronic intractable pain, as well as an adjunctive treatment in the management of post-surgical pain, post-traumatic acute pain problems, and an adjunct for pain control due to rehabilitation.

1 Aug 2017

LivaNova's latest VNS Therapy earns CE Mark for expanded MRI labeling

LivaNova PLC , a market-leading medical technology company, today announced its latest VNS Therapy Systems ("VNS Therapy") received CE Mark for expanded MRI labeling. VNS Therapy is now the only implantable device indicated for epilepsy therapy that allows patients to have high-quality 1.5T and 3T MRI scans without the need for special equipment.

1 Aug 2017

Study: DBS shows promise for treating patients with post-stroke pain syndrome

Deep brain stimulation (DBS) of the ventral striatum/anterior limb of the internal capsule is safe and feasible in addressing the affective component of pain in patients with post-stroke pain syndrome.

20 Jun 2017

World’s first Percutaneous Injectable Anchor System receives CE Mark approval

Freedom Neuro BV, a medical device distributor for Stimwave Technologies Incorporated, today announced CE Mark approval for the world's first Percutaneous Injectable Anchor System.

27 May 2017

EHRA EUROPACE - CARDIOSTIM 2017 to showcase holographic cardiac imaging and other innovations

Holographic cardiac imaging and other innovations will be showcased at the EHRA EUROPACE - CARDIOSTIM 2017 in Vienna, Austria.

18 May 2017

Discovery of signaling pathway offers new functional framework for treating schizophrenia

Neuroscientists at Tufts University School of Medicine have discovered a new signaling pathway that directly connects two major receptors in the brain associated with learning and memory – the N-methyl-D-aspartate receptor (NMDAR) and the alpha 7 nicotinic acetylcholine receptor (a7nAChR) – which has significance for current efforts to develop drugs to treat schizophrenia.

4 May 2017

Clinicians use 3D printing to treat woman with degenerative spinal condition

Clinicians recently used 3D printing to help treat a woman with a degenerative condition of the spinal column.

20 Apr 2017

New NSF Industry/University Cooperative Research Center to focus on developing neural technologies

Neurological disorders like Parkinson's, the aftermath of stroke, limb loss and paralysis significantly diminish the length and quality of life -- affecting about one in six people worldwide.

18 Apr 2017

Study finds thalamic DBS to be safe, effective treatment for young adults with Tourette syndrome

A surgical technique that sends electrical impulses to a specific area of the brain reduces the "tics," or involuntary movements and vocal outbursts, experienced by young adults with severe cases of Tourette syndrome, according to a new study led by investigators from NYU Langone Medical Center.

7 Apr 2017

Experts to present diverse advances in neuromodulation at INS congress

Experts will present diverse advances in neuromodulation from May 27 to June 1, 2017 at the 13th World Congress of the International Neuromodulation Society in Edinburgh, Scotland.

30 Mar 2017

Deep brain stimulation may help improve mental, physical health in patients with anorexia nervosa

Deep brain stimulation might alter the brain circuits that drive anorexia nervosa symptoms and help improve patients’ mental and physical health, according to a small study published in The Lancet Psychiatry.

25 Feb 2017

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain.

20 Jan 2017

INS experts publish new consensus on neuromodulation therapy

The International Neuromodulation Society journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of neuromodulation implants in patient-centered therapy.

2 Jan 2017

PathMaker Neurosystems receives 2016 Universal Biotech Innovation Prize

PathMaker Neurosystems, a clinical-stage neurotechnology company developing non-invasive neurotherapy systems to treat neuromotor disorders, has been named as the Recipient of the Universal Biotech Innovation Prize 2016 in the global competition that offers "a glimpse of the future of life sciences."

19 Oct 2016

UAB investigators receive BRAIN Initiative award to study new DBS technology for Parkinson's disease

The University of Alabama at Birmingham has received a BRAIN Initiative grant of $7.3 million over five years from the National Institutes of Health to study new technology that could improve outcomes from deep brain stimulation, an increasingly important treatment for Parkinson's disease and other movement disorders.

18 Oct 2016

RTI extends research support to improve treatment for pelvic floor disorders in women

RTI International will continue supporting research efforts to improve clinical care for women with pelvic floor disorders as part of the Pelvic Floor Disorders Network.

6 Oct 2016

Noninvasive brain stimulation may curb cravings for appetitive foods

Available research suggests that noninvasive stimulation of a specific brain area can reduce food cravings—particularly for high-calorie, "appetitive" foods, according to a review in the Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Wolters Kluwer.

20 Jul 2016

Study provides more insight into effects of DBS in treatment of Alzheimer's disease

New findings published today by a team of researchers led by Dr. Andres Lozano at the Krembil Neuroscience Centre of Toronto Western Hospital have provided further insight into the effects of Deep Brain Stimulation (DBS) in the treatment of Alzheimer's disease.